Migraine and comorbid pain

Зенкевич, А. С.; Filatova, E G; Latysheva, N. V.

doi:10.21518/2079-701x-2016-8-106-115

Cited by 3 publications

(1 citation statement)

References 12 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…We speculated, on the basis of previous research, that the relief of neck pain improved the patients’ symptoms of migraine and prevented further migraine attacks. [ 40 – 52 ]…”

Section: Discussionmentioning

confidence: 99%

Acupuncture reduced the medical expenditure in migraine patients

et al. 2020

View full text Add to dashboard Cite

Objectives: According to the data of Organisation for Economic Cooperation and Development, almost all the countries got increased medical expenditures in these years. Among the diseases, migraine is a condition that affects predominantly young and middle-aged people. It results in great economic losses. So we perform this research to investigate the acupuncture effect of reducing medical expenditure and medical resources use. Perspective: Acupuncture is a non-pharmacologic treatment and it became popular in recent years. In Taiwan, about 13% migraine patients visited acupuncture doctor. We hypothesized that the acupuncture had the additional effect than the medical treatment. Setting: We analysed the economic cost and medical visits in the real word. Methods: We used national cohort data from Taiwan, retrospectively gathered between 2000 and 2010. We selected newly diagnosed migraine patients who were diagnosed by registered neurologists formally licensed by the Taiwan Neurological Society. We divided these patients into two groups: with and without acupuncture treatment. The main outcome was medical expenditures and visits within 1 year after acupuncture. Results: In migraine patients who received acupuncture treatment, medical expenditures on emergency care and hospitalization were significantly lower than the group without acupuncture treatment. Conclusion: According to our real-world data, acupuncture can reduce the medical expenditure in migraine patients within 1 year after diagnosis. For the health policy maker, it is cost effective to encourage combining acupuncture and western medicine to treat migraine patients. For the doctors in routine clinical practice, who may consider to consult acupuncture doctors to deal with the migraine patients together.

show abstract

“…We speculated, on the basis of previous research, that the relief of neck pain improved the patients’ symptoms of migraine and prevented further migraine attacks. [ 40 – 52 ]…”

Section: Discussionmentioning

confidence: 99%

Acupuncture reduced the medical expenditure in migraine patients

et al. 2020

View full text Add to dashboard Cite

show abstract

Temporomandibular disorder as the most prevalent cause of facial pain: current evidence

Latysheva

Филатова

Осипова

2017

Z. nevrol. psikhiatr. im. S.S. Korsakova

Self Cite

View full text Add to dashboard Cite

Orofacial pain is a comprehensive and multi-faceted syndrome. After dental causes have been excluded, neurologists are challenged to diagnose the cause of pain. The paper gives a detailed review of one of the most common causes of facial pain - temporomandibular disorder (TMD). Current DC/TMD diagnostic criteria, patient examination protocols and a new perspective on TMD pathophysiology based on the recent neurological studies are presented. The article also discusses modern approaches to TMD management.

show abstract

Impact of anti-CGRP monoclonal antibodies on central sensitization level in migraine patients

Berdnikova,

Kadymova,

Latysheva

et al. 2024

Medicinskij alfavit

View full text Add to dashboard Cite

Background. Central sensitization (CS) is the mechanism underlying chronic migraine and other conditions combined into a group of central sensitivity syndromes. The most reliable method for assessing the severity of CS is Central Sensitization Inventory (CSI).Aim. The aim of our study is the evaluation of anti-CGRP monoclonal antibodies (erenumab, fremanezumab) effect on the central sensitization level in migraine patients.Material and methods. We recruited 90 patients over 18 years old diagnosed with episodic migraine (EM) and chronic migraine (CM) according to the International Classification of Headache Disorders, 3rd edition. All patients were from November 2020 to March 2022. Demographic data, history of migraine and previous migraine treatment were collected for each patient. All patients filled out CSI. Dynamics was followed up monthly with headache diaries.Results. After six months of treatment the level of CS in the CM group significantly decreased from the initial level of 41 (32.0, 50.5) to 36 (25.0, 39.0), which corresponds to the absence of clinically significant CS, p = 0.02*. The analysis of points of the CSI after 3 months of treatment shows a significant decrease in the prevalence of pain syndromes, cognitive impairment, asthenic disorders, hypersensitivity and affective disorders.Conclusions. The use of erenumab and fremanezumab is advisable in patients with migraine and comorbid conditions based on the CS mechanism.

show abstract

Migraine and comorbid pain

Cited by 3 publications

References 12 publications

Acupuncture reduced the medical expenditure in migraine patients

Acupuncture reduced the medical expenditure in migraine patients

Temporomandibular disorder as the most prevalent cause of facial pain: current evidence

Impact of anti-CGRP monoclonal antibodies on central sensitization level in migraine patients

Contact Info

Product

Resources

About